B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
By A Mystery Man Writer
Description
Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients.
![B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®](https://mma.prnewswire.com/media/1096384/CytoSorbents_Working_To_Save_Lives_Logo.jpg)
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
![B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®](https://l450v.alamy.com/450v/fbw1f7/female-labours-works-at-a-cloth-factory-in-huaibei-city-anhui-province-fbw1f7.jpg)
In this image released on Tuesday, March 2, 2021, the CytoSorb® adsorber is used in critical care for the extracorporeal removal of cytokines and inflammatory mediators from the bloodstream. B. Braun Avitum
![B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®](https://l450v.alamy.com/450v/w0mkem/this-nasa-image-released-on-may-17-2012-shows-the-spacex-falcon-9-rocket-standing-atop-space-launch-complex-40-at-cape-canaveral-air-force-station-in-florida-spacex-has-confirmed-that-they-will-re-attempt-to-launch-the-rocket-tuesday-may-22-at-344-am-following-a-last-second-engine-shut-down-during-saturdays-launch-attempt-upinasa-w0mkem.jpg)
In this image released on Tuesday, March 2, 2021, the CytoSorb® adsorber is used in critical care for the extracorporeal removal of cytokines and inflammatory mediators from the bloodstream. B. Braun Avitum
![B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®](https://mma.prnewswire.com/media/1447291/B_Braun_Avitum_AG.jpg?p=facebook)
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
![B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®](https://l450v.alamy.com/450v/2jgrpay/220712-greenbelt-us-july-12-2022-xinhua-image-released-by-nasa-on-july-12-2022-shows-a-composite-image-of-the-cosmic-cliffs-in-the-carina-nebula-created-with-james-webb-space-telescopes-nircam-and-miri-nasa-released-james-webb-space-telescopes-first-full-color-images-of-the-universe-and-their-spectroscopic-data-on-tuesday-revealing-the-unprecedented-and-detailed-views-of-the-universe-nasa-esa-csa-stscihandout-via-xinhua-2jgrpay.jpg)
In this image released on Tuesday, March 2, 2021, the OMNI® extracorporeal platform is intended to perform continuous blood purification treatments and therapeutic plasma exchange. The OMNI® in combination with OMNIset®* disposable
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb® - Cytosorbents
![B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®](https://www.admin.surgi-plan.com/companyBackgroundImg/dda291bd303d4ef0af1ee0f6c9f90b3b.png)
新闻详情页-B. Braun Group
Digital Diabetes Management Market Size, Trends & Forecast
Digital Diabetes Management Market Size, Trends & Forecast
![B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®](https://cdn.open-pr.com/U/4/U405473787_g.jpg)
Apheresis Machines Market 2021: Comprehensive Study Explores
![B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®](http://www.admin.surgi-plan.com/file/1631521839586.jpg)
新闻详情页-B. Braun Group
from
per adult (price varies by group size)